SUVRETTA CAPITAL MANAGEMENT, LLC purchased 8.5% of their position (144.22K shares) of BENITEC BIOPHARMA INC. on the open market
Open‑market purchase worth $1.90M — a moderate purchase. The strongest form of insider conviction signal.
Common stock, par value $0.0001 per share
Shares
+42.60K
Price / share
$12.85
Trade value
$547.41K
% of position
Common stock, par value $0.0001 per share
Shares
+7.40K
Price / share
$12.85
Trade value
$95.09K
% of position
Common stock, par value $0.0001 per share
Shares
+14.32K
Price / share
$13.10
Trade value
$187.59K
% of position
Common stock, par value $0.0001 per share
Shares
+2.52K
Price / share
$13.10
Trade value
$32.96K
% of position
Common stock, par value $0.0001 per share
Shares
+65.80K
Price / share
$13.44
Trade value
$884.35K
% of position
Common stock, par value $0.0001 per share
Shares
+11.59K
Price / share
$13.44
Trade value
$155.73K
% of position
Net shares
+144.22K
Net value
$1.90M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.0001 per share Indirect | 12/23/2025 | P · Purchase | +42.60K | $12.85 | $547.41K | 0.4% | 9.58M | 9.62M |
| Common stock, par value $0.0001 per share Indirect | 12/23/2025 | P · Purchase | +7.40K | $12.85 | $95.09K | 0.4% | 1.83M | 1.83M |
| Common stock, par value $0.0001 per share Indirect | 12/26/2025 | P · Purchase | +14.32K | $13.10 | $187.59K | 0.1% | 9.62M | 9.63M |
| Common stock, par value $0.0001 per share Indirect | 12/26/2025 | P · Purchase | +2.52K | $13.10 | $32.96K | 0.1% | 1.83M | 1.84M |
| Common stock, par value $0.0001 per share Indirect | 12/29/2025 | P · Purchase | +65.80K | $13.44 | $884.35K | 0.7% | 9.63M | 9.70M |
| Common stock, par value $0.0001 per share Indirect | 12/29/2025 | P · Purchase | +11.59K | $13.44 | $155.73K | 0.6% | 1.84M | 1.85M |
| Total | +144.22K | $1.90M | ||||||